Coronary Artery Disease

Distributor announced for Angiometrx Metricath products

Published in Cardiovascular Week, May 17th, 2004

Possis Medical, Inc., (POSS) has signed a 3-year agreement with Angiometrx, Inc., a subsidiary of Medical Ventures Corporation, (MEV) to act as the exclusive distributor of the Angiometrx Metricath products in the United States.

Robert G. Dutcher, chairman and chief executive officer of Possis Medical, Inc., said, "We are pleased to be offering an innovative, synergistic product to our interventional cardiology customers, and we look forward to working with the responsive, customer-focused team at Angiometrx to develop the growth of their business as well as to pull-through additional business for the AngioJet System."

The Metricath System is an...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Week

Source: Cardiovascular Week (2004-05-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry